Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Incidence of metastatic uveal melanoma
15 evidence topics · 13 sources
U.S. age-adjusted incidence of uveal melanoma, SEER core registries, 1975 to 2020
“The overall mean age-adjusted incidence of primary uveal melanoma in the US over the 45-year period from 1975 to 2020 was 5.6 per million population (95% CI: 5.5–5.7).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“As previously noted, a small but statistically significant (p < 0.05) annual percentage change of 0.5% was detected in whites.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Age-adjusted incidence of uveal melanoma by sex
Incidence of uveal melanoma by race, ethnicity, sex, and age in 37,917 cases
“A total of 37,917 UM cases were identified, with an overall AAIR of 5.54 per million (95% CI: 5.48-5.59), showing a stable but slightly increasing trend (AAPC = 0.06).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Incidence was highest in non-Hispanic whites (6.87 ppm), men (6.25 ppm), and those aged 75-79 years.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Annual age-adjusted incidence of uveal melanoma by race and ethnicity
U.S. age-adjusted incidence of uveal melanoma and sex difference, NCI PDQ summary
Age at diagnosis of uveal melanoma
“Median age at diagnosis was 63 years (range: 5–90 years).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“UM occurs in patients of all ages; 1% of cases affect the paediatric population.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Incidence increases with age, rising to >20 cases per million by the age of 70.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Estimated U.S. new cases in 2026, all eye and orbit cancer
| Site, United States, 2026 | Estimated new cases, both sexes | Male | Female |
|---|---|---|---|
| Eye and orbit | “3200”View highlighted excerpt for this quote | “1720”View highlighted excerpt for this quote | “1480”View highlighted excerpt for this quote |
Worldwide geographic variation in incidence
“In a recent study, incidence that correlated with latitude was expressed as a north-to-south decreasing gradient, ranging from ≥8.0 cases per million person-years in Northern/Western Europe and Oceania, to 2.0-7.9 in North America, Eastern Europe and Southern Europe and <2.0 in South America, Asia and Africa.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
SEER stage at diagnosis of uveal melanoma
| SEER stage at diagnosis, uveal melanoma | N (%) |
|---|---|
| Localized | “6,126 (90.9)”View highlighted excerpt for this quote |
| Regional | “506 (7.5)”View highlighted excerpt for this quote |
| Distant | “109 (1.6)”View highlighted excerpt for this quote |
Detectable metastases at diagnosis of the primary tumor
“Of 3610 patients with uveal melanoma, 69 (1.9%; 95% CI 1.5 to 2.4) presented with clinical metastasis (stage IV).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Risk of synchronous metastases increased from 0.7% (T1) to 1.5% (T2), 2.6% (T3) and 7.9% (T4).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Proportion of patients who develop metastases after treatment of the primary tumor
“Although local therapy is effective for local control in >90% of cases, up to 50% of patients will develop metastases, mainly in the liver (90%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Unfortunately, up to 50% of patients with uveal melanoma will ultimately develop metastatic disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Treatment of primary uveal melanoma with radiotherapy, enucleation or other modalities achieves local control in more than 90% of patients, although 40% or more ultimately develop distant metastases, most commonly in the liver.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cumulative incidence of metastasis at 5 and 10 years, COMS trials
“Seven hundred thirty-nine patients were diagnosed with at least 1 site of metastasis during follow-up after treatment for choroidal melanoma. Five- and 10-year cumulative metastasis rates were 25% (95% confidence interval, 23%-27%) and 34% (95% confidence interval, 32%-37%), respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Risk of metastasis by AJCC stage and tumor thickness
“The AJCC Cancer Staging Manual is an anatomy-based system; tumour diameter and thickness, ciliary body involvement and extraocular extension are factors associated with the risk of metastasis at 10 years from 5% for stage I to 40% for stage III.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Small thickness UM (0-3 mm in thickness) was associated with a 5- and 10-year metastatic risk of 6% and 12%. The 5-/10-year metastatic risk of medium thickness (3.1-8 mm) and large tumors (>8 mm in thickness) was 14%/26% and 35%/49%, respectively” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Annual number of new U.S. cases of metastatic uveal melanoma
No evidence found.